Bal Pharma has informed that with reference to Regulation 30 of SEBI (LODR) Regulations, 2015 and further to intimation dated 25/02/2020 regarding resignation of Pramod Kumar.S as independent Director of the Company; the Company has submitting the confirmation received from Pramod Kumar.S as per Regulation 30, Clause 7B of Schedule III of SEBI(LODR) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.